Mutations in the hemochromatosis gene (HFE) and multiple sclerosis

21Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the present study we have investigated whether HFE gene polymorphism may play a role in the disease process of Croatian and Slovenian MS patients and their potential genetic susceptibility to MS. We genotyped 314 MS patients and 400 healthy controls for the C282Y and H63D mutations by polymerase chain reaction/restriction fragment length polymorphism (PCR-RFLP) analysis. Our results showed no significant differences in the distribution of the two mutations between MS patients and controls, suggesting that HFE polymorphisms do not contribute to the susceptibility to MS. Also, there was no significant correlation between HFE polymorphism and the disease progression index. However, we observed that MS patients carrying the mutant C282Y allele exhibited earlier onset of disease symptom relative to other genotypes, but it warrants further study in a larger series of MS patients. © 2005 Elsevier Ireland Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Ristić, S., Lovrečić, L., Brajenović-Milić, B., Starčević-Čizmarević, N., Jazbec, S. Š., Sepčić, J., … Peterlin, B. (2005). Mutations in the hemochromatosis gene (HFE) and multiple sclerosis. Neuroscience Letters, 383(3), 301–304. https://doi.org/10.1016/j.neulet.2005.04.045

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free